Stay updated on Isatuximab for High-Risk Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.

Latest updates to the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history, and the previous v3.6.5 entry was removed. This updates the record’s version history rather than altering study content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry v3.6.5 was added to the study's history, and the previous entry v3.6.4 was removed, updating the documented version history. This reflects an update to the audit trail of the trial record.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision entry (v3.6.4) was added to the record history and the previous revision (v3.6.3) was removed, indicating an administrative update to the page's revision history.SummaryDifference0.1%

- Check70 days agoChange DetectedThe history entry now shows Revision: v3.6.3 in place of the previous v3.6.2, signaling a new version of the record page. This reflects an update to the page metadata and navigation history rather than substantive study content.SummaryDifference0.1%

- Check77 days agoChange DetectedThe record history page shows a new revision tag (v3.6.2) replacing the previous v3.6.0, indicating a template or UI update to the history view. This does not alter any study data or listed records.SummaryDifference0.1%

- Check92 days agoChange DetectedThe recruitment status changes to no longer looking for participants. The page revision is updated to v3.6.0 (from v3.5.5).SummaryDifference0.2%

Stay in the know with updates to Isatuximab for High-Risk Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.